Weak Keys in MST1

被引:0
|
作者
Jens-Matthias Bohli
Rainer Steinwandt
María Isabel González Vasco
Consuelo Martínez
机构
[1] Universität Karlsruhe,Institut für Algorithmen und Kognitive Systeme, Arbeitsgruppe Systemsicherheit, Prof. Dr. Th. Beth
[2] Universidad Rey Juan Carlos,A´rea de Matemática Aplicada
[3] Universidad de Oviedo,Departamento de Matemáticas
来源
Designs, Codes and Cryptography | 2005年 / 37卷
关键词
public key cryptography; cryptanalysis; group factorizations; logarithmic signatures; finite permutation groups; 94A60; 20B40;
D O I
暂无
中图分类号
学科分类号
摘要
The public key cryptosystem MST1 has been introduced by Magliveras et al. [12] (Public Key Cryptosystems from Group Factorizations. Jatra Mountain Mathematical Publications). Its security relies on the hardness of factoring with respect to wild logarithmic signatures. To identify ‘wild-like’ logarithmic signatures, the criterion of being totally-non-transversal has been proposed. We present tame totally-non-transversal logarithmic signatures for the alternating and symmetric groups of degree ≥ 5. Hence, basing a key generation procedure on the assumption that totally-non-transversal logarithmic signatures are ‘wild like’ seems critical. We also discuss the problem of recognizing ‘weak’ totally-non-transversal logarithmic signatures, and demonstrate that another proposed key generation procedure based on permutably transversal logarithmic signatures may produce weak keys.
引用
收藏
页码:509 / 524
页数:15
相关论文
共 50 条
  • [21] Rassf Proteins as Modulators of Mst1 Kinase Activity
    Bitra, Aruna
    Sistla, Srinivas
    Mariam, Jessy
    Malvi, Harshada
    Anand, Ruchi
    SCIENTIFIC REPORTS, 2017, 7
  • [22] Rassf1A inhibits cardiac hypertrophy through Mst1
    Matsuda, Takahisa
    Zhai, Peiyong
    Gao, Shumin
    Clark, Geoffrey J.
    Van der Weyden, Louise
    Sadoshima, Junichi
    CIRCULATION RESEARCH, 2007, 101 (05) : E73 - E74
  • [23] The Role of Mst1 and Mst2 in Pressure Overload-Induced Hypertrophy and Failure
    Del Re, Dominic P.
    Yamamoto, Takanobu
    Zhai, Peiyong
    Sadoshima, Junichi
    CIRCULATION, 2013, 128 (22)
  • [24] RASSF1C DECREASES MST1/2 ACTIVATION
    Palma, A. E.
    Poh, C.
    Alfakhouri, M.
    Amaar, Y.
    Reeves, M.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2012, 60 (01) : 191 - 191
  • [25] Pharmacological targeting of kinases MST1 and MST2 augments tissue repair and regeneration
    Fan, Fuqin
    He, Zhixiang
    Kong, Lu-Lu
    Chen, Qinghua
    Yuan, Quan
    Zhang, Shihao
    Ye, Jinjin
    Liu, Hao
    Sun, Xiufeng
    Geng, Jing
    Yuan, Lunzhi
    Hong, Lixin
    Xiao, Chen
    Zhang, Weiji
    Sun, Xihuan
    Li, Yunzhan
    Wang, Ping
    Huang, Lihong
    Wu, Xinrui
    Ji, Zhiliang
    Wu, Qiao
    Xia, Ning-Shao
    Gray, Nathanael S.
    Chen, Lanfen
    Yun, Cai-Hong
    Deng, Xianming
    Zhou, Dawang
    SCIENCE TRANSLATIONAL MEDICINE, 2016, 8 (352)
  • [26] Neratinib is an MST1 inhibitor and restores pancreatic β-cells in diabetes
    Amin Ardestani
    Matthew S. Tremblay
    Weijun Shen
    Kathrin Maedler
    Cell Death Discovery, 5
  • [27] Mst1 coordinately regulates autophagy and apoptosis in diabetic cardiomyopathy
    Zhang Mingming
    Wang, Haichang
    Sun, Dongdong
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (16) : C42 - C43
  • [28] Mst1 inhibits PGC-1α via inhibition of CREB
    Zablocki, Daniela K.
    Ago, Tetsuro
    Sadoshima, Junichi
    CIRCULATION, 2007, 116 (16) : 141 - 141
  • [29] Rassf1A inhibits cardiac hypertrophy through Mst1
    Matsuda, Takahisa
    Zhai, Peiyong
    Gao, Shumin
    Clark, Geoffrey J.
    Weyden, Louise V.
    Sadoshima, Junichi
    CIRCULATION, 2007, 116 (16) : 95 - 95
  • [30] MST1 deletion protects β-cells in a mouse model of diabetes
    Amin Ardestani
    Kathrin Maedler
    Nutrition & Diabetes, 12